SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-04-02 11:25
Tx date 2024-04-01 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$5,492
+632 vol
$8.69 each 		179,796
Filed 2024-04-02 11:23
Tx date 2024-04-01 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-1,264 vol 		179,164
Filed 2024-03-28 17:29
Tx date 2024-03-28 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-4,837.20
-556 vol
$8.70 each 		180,428
Filed 2024-03-27 20:03
Tx date 2024-03-27 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+5,173 vol 		180,984
Filed 2024-03-27 12:36
Tx date 2024-03-26 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-5,220
-600 vol
$8.70 each 		175,811
Filed 2024-03-19 11:27
Tx date 2024-03-15 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$3,078
+403 vol
$7.64 each 		176,411
Filed 2024-01-03 12:37
Tx date 2024-01-02 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$10,346
+1,156 vol
$8.95 each 		176,008
Filed 2024-01-03 12:35
Tx date 2024-01-02 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-2,313 vol 		174,852
Filed 2023-10-05 07:27
Tx date 2023-10-02 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$9,023
+1,148 vol
$7.86 each 		177,165
Filed 2023-10-05 07:25
Tx date 2023-10-02 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-2,297 vol 		176,017
Filed 2023-07-01 08:15
Tx date 2023-06-30 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$8,568
+1,144 vol
$7.49 each 		178,314
Filed 2023-07-01 08:14
Tx date 2023-06-30 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+2,289 vol 		177,170
Filed 2023-04-02 14:38
Tx date 2023-03-31 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+5,633 vol 		174,881
Filed 2023-04-02 14:36
Tx date 2023-03-31 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+1,138 vol 		169,248
Filed 2023-04-02 14:34
Tx date 2023-03-31 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-2,277 vol 		168,110
Filed 2023-03-24 16:59
Tx date 2022-12-31 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$727.18
+103 vol
$7.06 each 		170,387
Filed 2022-04-01 11:35
Tx date 2022-03-31 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+4,292 vol 		170,284
Filed 2021-03-20 12:51
Tx date 2021-03-19 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+4,897 vol 		165,992
Filed 2020-04-01 09:55
Tx date 2020-03-31 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+9,003 vol 		161,095
Filed 2019-12-24 18:41
Tx date 2002-06-25 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Holder: AQUIAM (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		500,000
Filed 2018-12-14
Tx date 2018-12-14 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Carson RESP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-21,600
-2,700 vol
$8.00 each 		0
Filed 2018-12-14
Tx date 2018-12-14 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-4,000
-500 vol
$8.00 each 		152,092
Filed 2018-12-14
Tx date 2018-12-14 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-4,800
-600 vol
$8.00 each 		0
Filed 2018-06-01
Tx date 2018-06-01 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,920
+400 vol
$9.80 each 		152,592
Filed 2018-01-09
Tx date 2018-01-08 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options 		$10,905
+1,136 vol
$9.60 each 		49,058
Filed 2017-12-05
Tx date 2017-12-05 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-5,100
-500 vol
$10.20 each 		600
Filed 2017-12-04
Tx date 2017-12-04 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-5,150
-500 vol
$10.30 each 		1,100
Filed 2017-12-04
Tx date 2017-12-04 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-5,150
-500 vol
$10.30 each 		1,600
Filed 2017-11-24
Tx date 2017-11-24 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-5,125
-500 vol
$10.25 each 		2,100
Filed 2017-11-23
Tx date 2017-11-23 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Holder: Tara RESP (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-5,100
-500 vol
$10.20 each 		2,600
Filed 2017-03-15
Tx date 2017-03-15 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options 		$9,158
+1,246 vol
$7.35 each 		47,922
Filed 2016-03-31
Tx date 2016-03-31 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$4,414
+992 vol
$4.45 each 		152,192
Filed 2016-03-31
Tx date 2016-03-31 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$3,549
+3,900 vol
$0.91 each 		151,200
Filed 2016-02-18
Tx date 2016-02-12 		$RX
BioSyent Inc. 		Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
Common Shares - Options
50 - Grant of options 		$7,613
+1,228 vol
$6.20 each 		46,676